Expression of endothelin-1 and its receptors in cisplatin-induced acute renal failure in mice

Korean Journal of Physiology and Pharmacology

Volumn 12, Issue 4, 2008, Pages 149-153

  Lee, Seokwoo ^a   Ahn, Dowhan ^a  

^a Kosin University College of Medicine   (South Korea)

Author keywords

Acute renal failure; Cisplatin; Endothelin; Endothelin receptor

Indexed keywords

CISPLATIN; ENDOTHELIN 1; ENDOTHELIN RECEPTOR; MESSENGER RNA;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MOUSE; NEPHROTOXICITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; WESTERN BLOTTING;

EID: 52349087404     PISSN: 12264512     EISSN: None     Source Type: Journal    
DOI: 10.4196/kjpp.2008.12.4.149     Document Type: Article

References (21)

1. Ahn D, Ge Y, Stricklett PK, Gill P, Taylor D, Hughes AK, Yanagisawa M, Miller L, Nelson RD, Kohan DE. Collecting duct-specific knockout of endothelin-1 causes hypertension and sodium retention. J Clin Invest 114: 504-511, 2004
2. Birck R, Knoll T, Braun C, Kirchengast M, Munter K, van der Woude FJ, Rohmeiss P. Improvement of postischemic acute renal failure with the novel orally active endothelin-A receptor antagonist LU 135252 in the rat. J Cardiovasc Pharmacol 32: 80-86, 1998
3. Braun C, Conzelmann T, Vetter S, Schaub M, Back WE, Yard B, Kirchengast M, Tullius SG, Schnulle P, van der Woude FJ, Rohmeiss P. Prevention of chronic renal allograft rejection in rats with an oral endothelin A receptor antagonist. Transplantation 68: 739-746, 1999
4. Chatziantoniou C, Dussaule JC. Insights into the mechanisms of renal fibrosis: is it possible to achieve regression? Am J Physiol Renal Physiol 289: F227-234, 2005
5. Deng DX, Jiang J, Garcia B, Zhong R, Chakrabarti S. Endothelin-1, endothelin-3 and their receptors (endothelin (A) and endothelin (B)) in chronic renal transplant rejection in rats. Transpl Int 13: 175-182, 2000
6. Forbes JM, Jandeleit-Dahm K, Allen TJ, Hewitson TD, Becker GJ, Jones CL. Endothelin and endothelin A/B receptors are increased after ischaemic acute renal failure. Exp Nephrol 9: 309-316, 2001
7. Francis BN, Abassi Z, Heyman S, Winaver J, Hoffman A. Differential regulation of ETA and ETB in the renal tissue of rats with compensated and decompensated heart failure. J Cardiovasc Pharmacol 44: S362-S365, 2004
8. Gellai M, Jugus M, Fletcher T, DeWolf R, Nambi P. Reversal of postischemic acute renal failure with a selective endothelinA receptor antagonist in the rat. J Clin Invest 93: 900-906, 1994
9. Hoffman A, Grossman E, Goldstein DS, Gill JR, Jr., Keiser HR. Urinary excretion rate of endothelin-1 in patients with essential hypertension and salt sensitivity. Kidney Int 45: 556-560, 1994
10. Kuro T, Kohnou K, Kobayashi Y, Takaoka M, Opgenorth TJ, Wessale JL, Matsumura Y. Selective antagonism of the ETA receptor, but not the ETB receptor, is protective against ischemic acute renal failure in rats. Jpn J Pharmacol 82: 307-316, 2000
11. Nakamura T, Ebihara I, Fukui M, Osada S, Tomino Y, Masaki T, Goto K, Furuichi Y, Koide H. Modulation of glomerular endothelin and endothelin receptor gene expression in aminonucleoside-induced nephrosis. J Am Soc Nephrol 5: 1585-1590, 1995
12. Nelson J, Baguato A, Battistini B, Nisen P. The endothelin axis: emerging role in cancer. Nat Rev Cancer 3: 110-116, 2003
13. Ong AC, Newby LJ, Dashwood MR. Expression and cellular localisation of renal endothelin-1 and endothelin receptor subtypes in autosomal-dominant polycystic kidney disease. Nephron Exp Nephrol 93: e80, 2003
14. Ramesh G, Reeves WB. TNF-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity. J Clin Invest 110: 835-842, 2002
15. Roubert P, Gillard-Roubert V, Pourmarin L, Cornet S, Guilmard C, Plas P, Pirotzky E, Chabrier PE, Braquet P. Endothelin receptor subtypes A and B are up-regulated in an experimental model of acute renal failure. Mol Pharmacol 45: 182-188, 1994
16. Schellmann RG, Kelly KJ. Pathophysiology of nephrotoxic acute renal failure. In: Schrier RW ed, Atlas of Diseases of the Kidney. 1st ed. Current medicine Inc., Philadelphia, p 15.1-15.14, 1999
17. Sheridan AM, Bonventre JV. Pathophysiology of ischemic acute renal failure. Contrib Nephrol 7-21, 2001
18. Shimizu T, Kuroda T, Ikeda M, Hata S, Fujimoto M. Potential contribution of endothelin to renal abnormalities in glycerol-induced acute renal failure in rats. J Pharmacol Exp Ther 286: 977-983, 1998
19. Stein JH, Lifschitz MD, Barnes LD. Current concepts on the pathophysiology of acute renal failure. Am J Physiol 234: F171-181, 1978
20. Takaoka M, Kuro T, Matsumura Y. Role of endothelin in the pathogenesis of acute renal failure. Drug News Perspect 13: 141-146, 2000
21. Yoshimura A, Iwasaki S, Inui K, Ideura T, Koshikawa S, Yanagisawa M, Masaki T. Endothelin-1 and endothelin B type receptor are induced in mesangial proliferative nephritis in the rat. Kidney Int 48: 1290-1297, 1995